Advertisement
AFL vs CNO
Which Stock Would AI Choose? Aflac Incorporated (AFL) vs. CNO Financial Group (CNO) Stock Comparison
Key Takeaways
- AFL (Aflac Incorporated) is a large-cap supplemental health and life insurer with major operations in Japan and the U.S., while CNO (CNO Financial Group) is a mid-cap life and health insurer focused on middle-income Americans.
- CNO has shown stronger recent momentum, breaking to a 52-week high and raising full-year earnings guidance twice in 2026, whereas AFL has traded more defensively amid cybersecurity and Japan premium headwinds.
- AFL stands out for capital stability and shareholder returns, including more than four decades of consecutive dividend increases.
- Tickeron AI Verdict: CNO is the ticker of choice in this comparison, based on relative trend consistency and near-term momentum.
- Explore further market context on AFL Major News, AFL Today's Price Move, CNO Major News, and CNO Today's Price Move for the latest developments and price action.
- Discover curated, market-ready trading strategies on the Trending AI Robots page.
Introduction
Insurance stocks often attract investors looking for steady cash flow, defensive positioning, and shareholder-friendly capital policies. This stock comparison examines two distinct names in the U.S. life and health insurance space: AFL, the Japan-heavy supplemental insurance giant Aflac Incorporated, and CNO, the middle-income-focused CNO Financial Group. While both operate in related markets, their growth drivers, geographic exposure, and recent momentum differ meaningfully. This comparison may be relevant to income-oriented investors evaluating dividend durability, as well as traders assessing relative performance and market positioning between a large-cap defensive name and a smaller-cap growth story.
AFL Overview and Recent Performance
AFL, or Aflac Incorporated, is one of the largest providers of supplemental health and life insurance in the United States and Japan. The company sells cancer, medical, dental, vision, disability, and long-term-care products primarily through workplace and direct-to-consumer channels, with its Japan segment historically generating the majority of revenue.
In recent market activity, AFL has delivered mixed results. Its latest quarterly report showed total revenue up sharply year over year, while adjusted earnings per share rose modestly, supported by share repurchases. However, sentiment has been tempered by a few factors: softer net earned premiums in Japan, a weaker yen-to-dollar exchange rate, and reported fallout from a cybersecurity incident. Analysts have issued a generally neutral "Hold" consensus, with price targets clustered in a wide range. On the positive side, the company maintains strong capital levels, returns billions to shareholders through buybacks and dividends, and continues its decades-long streak of annual dividend increases, underscoring a defensive, income-oriented profile.
CNO Overview and Recent Performance
CNO, or CNO Financial Group, is a holding company providing life and health insurance, annuities, and workplace benefits to middle-income pre-retirees and retirees through brands including Bankers Life, Colonial Penn, Optavise, and Washington National. The company distributes through both consumer and worksite divisions.
Recent market activity has favored CNO. Its latest quarterly results exceeded consensus estimates, driven by higher operating earnings and improved investment income, and management raised full-year operating earnings guidance for a second consecutive quarter. The stock responded by climbing to a 52-week high, with year-to-date returns well ahead of the broader market. Supporting the narrative are a multi-year streak of consecutive premium sales growth, improving operating return on equity (ROE), and capital-efficiency efforts through Bermuda reinsurance arrangements. At the same time, a portion of the recent earnings beat stemmed from one-time actuarial and investment items, and sales growth has shown signs of cooling, which investors continue to weigh against the stronger headline momentum.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots designed to navigate shifting market conditions. While Tickeron hosts hundreds of AI trading bots trading thousands of different tickers, only those best suited to the current environment earn a place in this featured section. These bots vary widely in trading style, strategy, timeframe, performance statistics, and the sets of tickers they trade, giving users a range of approaches to evaluate. The curated list helps traders and investors focus on systems demonstrating relevance and adaptability rather than sifting through the full catalog. Explore the Trending AI Robots page to review current selections and identify strategies aligned with your objectives.
Head-to-Head Comparison
Although both companies operate in life and health insurance, their business models and risk profiles diverge. AFL carries substantial foreign-exchange exposure through its Japan segment and skews toward stable, dividend-heavy shareholder returns, making it a more defensive, large-cap proposition. Its growth narrative depends on product refreshes in Japan and U.S. group benefits expansion, while headwinds include premium declines and cybersecurity-related costs.
CNO, by contrast, offers a smaller-cap growth story anchored in the middle-income U.S. market, with catalysts tied to Medicare Supplement repricing, fixed indexed annuity growth, and a technology-modernization program. Its risk factors include reliance on actuarial and investment tailwinds, decelerating sales growth, and elevated Medicare Supplement morbidity. In terms of relative performance, CNO has demonstrated stronger recent momentum and trend consistency, while AFL offers greater scale, liquidity, and dividend stability. Investors weighing these names are effectively comparing defensive income durability against higher-beta momentum.
Tickeron AI Verdict
Based on observable factors including trend consistency, recent momentum, and catalyst visibility, Tickeron's AI would likely favor CNO in the current market environment. The stock's breakout to a 52-week high, consecutive guidance raises, and sustained streak of premium sales growth reflect a stronger near-term trend profile than AFL's more range-bound, defensive positioning. CNO's improving operating ROE and capital-efficiency initiatives add constructive catalysts, while AFL faces comparatively softer headline headwinds in Japan and cybersecurity-related overhangs. This assessment is probabilistic and grounded in relative positioning rather than a definitive forecast, and it may shift as new data emerges.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFL is a StrongBuy and CNO is a Buy.
Momentum Indicator for AFL turns positive, indicating new upward trend
AFL saw its Momentum Indicator move above the 0 level on October 08, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned positive. In 47 of the 76 cases, the stock moved higher in the following days. The odds of a move higher are at 62%.
Technical Analysis (Indicators)
Bullish Trend Analysis
AFL moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AFL crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.
Following a +1.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where AFL advanced for three days, in 200 of 365 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.
The Aroon Indicator entered an Uptrend today. In 141 of 277 cases where AFL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 51%.
Bearish Trend Analysis
The 10-day RSI Indicator for AFL moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 21 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 54%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 30 of 64 cases where AFL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 47%.
AFL broke above its upper Bollinger Band on October 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 32 (best 1 - 100 worst), indicating outstanding price growth. AFL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 61 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.052) is normal, around the industry mean (1.337). P/E Ratio (13.325) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (0.463). Dividend Yield (0.020) settles around the average of (0.047) among similar stocks. AFL's P/S Ratio (3.313) is slightly higher than the industry average of (1.303).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
CNO in upward trend: 10-day moving average broke above 50-day moving average on October 26, 2026
The 10-day moving average for CNO crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for CNO just turned positive on October 15, 2026. Looking at past instances where CNO's MACD turned positive, the stock continued to rise in 30 of 47 cases over the following month. The odds of a continued upward trend are 64%.
CNO moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNO advanced for three days, in 210 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 184 of 296 cases where CNO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
Bearish Trend Analysis
The 10-day RSI Indicator for CNO moved out of overbought territory on November 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 22 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 55%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 33 of 68 cases where CNO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 49%.
The Momentum Indicator moved below the 0 level on November 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CNO as a result. In 43 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 49%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 46%.
CNO broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.980) is normal, around the industry mean (1.337). P/E Ratio (18.733) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.210) is also within normal values, averaging (0.463). Dividend Yield (0.013) settles around the average of (0.047) among similar stocks. P/S Ratio (1.156) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
AFL | CNO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 38 | 48 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | 62 Fair valued | |
PROFIT vs RISK RATING 1..100 | 3 | 3 | |
SMR RATING 1..100 | 94 | 94 | |
PRICE GROWTH RATING 1..100 | 32 | 41 | |
P/E GROWTH RATING 1..100 | 61 | 14 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CNO's Valuation (62) in the Life Or Health Insurance industry is in the same range as AFL (78). This means that CNO’s stock grew similarly to AFL’s over the last 12 months.
CNO's Profit vs Risk Rating (3) in the Life Or Health Insurance industry is in the same range as AFL (3). This means that CNO’s stock grew similarly to AFL’s over the last 12 months.
CNO's SMR Rating (94) in the Life Or Health Insurance industry is in the same range as AFL (94). This means that CNO’s stock grew similarly to AFL’s over the last 12 months.
AFL's Price Growth Rating (32) in the Life Or Health Insurance industry is in the same range as CNO (41). This means that AFL’s stock grew similarly to CNO’s over the last 12 months.
CNO's P/E Growth Rating (14) in the Life Or Health Insurance industry is somewhat better than the same rating for AFL (61). This means that CNO’s stock grew somewhat faster than AFL’s over the last 12 months.
| AFL | CNO | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 54% | 3 days ago 55% |
| Stochastic ODDS (%) | 3 days ago 47% | 3 days ago 49% |
| Momentum ODDS (%) | 7 days ago 62% | 3 days ago 49% |
| MACD ODDS (%) | N/A | 3 days ago 64% |
| TrendWeek ODDS (%) | 3 days ago 57% | 3 days ago 62% |
| TrendMonth ODDS (%) | 3 days ago 53% | 3 days ago 61% |
| Advances ODDS (%) | 5 days ago 55% | 5 days ago 63% |
| Declines ODDS (%) | N/A | 10 days ago 46% |
| BollingerBands ODDS (%) | 3 days ago 48% | 3 days ago 54% |
| Aroon ODDS (%) | 3 days ago 51% | 3 days ago 62% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AFL’s FA Score shows that 2 FA rating(s) are green while CNO’s FA Score has 2 green FA rating(s).
- AFL’s FA Score: 2 green, 3 red.
- CNO’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AFL’s TA Score shows that 5 TA indicator(s) are bullish while CNO’s TA Score has 5 bullish TA indicator(s).
- AFL’s TA Score: 5 bullish, 3 bearish.
- CNO’s TA Score: 5 bullish, 5 bearish.
Price Growth
AFL (@Life/Health Insurance) experienced а +2.86% price change this week, while CNO (@Life/Health Insurance) price change was +3.64% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.49%. For the same industry, the average monthly price growth was +2.06%, and the average quarterly price growth was -2.59%.
Reported Earning Dates
AFL is expected to report earnings on Feb 03, 2027.
CNO is expected to report earnings on Feb 09, 2027.
Industries' Descriptions
@Life/Health Insurance (+0.49% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
Advertisement
AFL and
Correlation & Price change
A.I.dvisor indicates that over the last year, AFL has been loosely correlated with CNO. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AFL jumps, then CNO could also see price increases.